Safety of biologic agents after rituximab therapy in patients with rheumatoid arthritis

The safety of other biologic therapies in rheumatoid arthritis (RA) following B cell-depletion therapy with rituximab has not been established. This retrospective chart review of patients attending an outpatient rheumatology clinic aimed to assess the incidence of adverse events in patients receivin...

Descripción completa

Detalles Bibliográficos
Autores principales: Mishra, Richa, Singh, Vijay, Pritchard, Charles H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824288/
https://www.ncbi.nlm.nih.gov/pubmed/20091035
http://dx.doi.org/10.1007/s00296-009-1307-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824288/
https://www.ncbi.nlm.nih.gov/pubmed/20091035
http://dx.doi.org/10.1007/s00296-009-1307-7

Ejemplares similares